PD1

Clinical trials for PD1 explained in plain language.

Never miss a new study

Get alerted when new PD1 trials appear

Sign up with your email to follow new studies for PD1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Double-Target immunotherapy added to standard care for aggressive cervical cancer

Disease control By invitation only

Researchers are testing whether adding cadonilimab, an immunotherapy drug, to chemotherapy before and after standard chemoradiation can help women with high-risk, locally advanced cervical cancer. The trial enrolls 20 women who have not received prior treatment. Participants rece…

Matched conditions: PD1

Sponsor: Hubei Cancer Hospital • Aim: Disease control

Last updated Sep 20, 2026 00:00 UTC

PD1

Get alerted when new PD1 trials appear

Double-Target immunotherapy added to standard care for aggressive cervical cancer